Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Thrombotic AEs of Hemlibra (emicizumab) were 2.8 times more frequent than those of FVIII replacements. 2023-08-18 08:58
The Global Medical Robotics Conference 2023: A Deep Dive into China's Booming Surgical Robotics Landscape 2023-08-18 02:08
Neurophth Announces First Patient Dosed in Phase I/II Clinical Trial of Second Gene Therapy 2023-08-17 21:00
Minghui Pharmaceutical Inc. Announces First Patient Enrollment in the Phase 3 Clinical Study of MH004 Cream for Treatment of Mild to Moderate Atopic Dermatitis 2023-08-17 19:00
I-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updates 2023-08-17 18:00
2023WCLC Oral Presentation | Molecular Analysis Validates the Effectiveness of Tumor Tissue-Based and Plasma ctDNA Testing in Identifying NSCLC Patients with EGFR Exon20ins Eligible for Treatment with Sunvozertinib 2023-08-17 17:10
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024 2023-08-16 05:00
CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency 2023-08-16 01:00
Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis 2023-08-15 22:50
OnCusp Therapeutics Receives FDA Clearance for the Phase 1 Clinical Trial of CUSP06, Targeting Ovarian Cancer and Other Advanced Solid Tumors 2023-08-15 20:00
Former U.S. Representative Patrick J. Kennedy Joins Holmusk as a Strategic Advisor 2023-08-15 20:00
Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System 2023-08-15 16:52
Orthopedic brace can help reduce pain from Hallux Valgus - The Footing Health K releases Toe braces! 2023-08-14 20:00
Neurophth Secures Nearly 95 Million USD in Series C+ Financing for Gene Therapy Clinical Trials 2023-08-11 21:00
Nano Labs to Announce First Half of 2023 Financial Results on August 15, 2023 2023-08-11 20:00
Asieris Announces Positive Phase III Bridging Trial of Hexvix®, a Diagnostic Drug for Bladder Cancer 2023-08-11 17:00
WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services 2023-08-11 08:30
WuXi XDC and Boostimmune Sign MOU for Integrated Services 2023-08-11 08:30
HitGen Enters into DNA-Encoded Library Based Research Service Agreement with Nested Therapeutics 2023-08-10 21:30
Datasea Launches Innovative "Intelligent Acoustics" Subsidiary in Delaware, Unveiling AI-Integrated Offerings for US Market 2023-08-10 21:30
1 80 81 82 83 84 812